论文部分内容阅读
目的:对液基细胞学薄层涂片技术及TBS系统在子宫颈癌早期筛查及宫颈病变诊断中的临床应用价值进行评价。方法:2007年3月16日至2007年6月31日在朝阳市中心医院妇产科门诊就诊的630例患者经TCT检查和TBS细胞学分类诊断,对TCT检查发现异常的患者进行阴道镜病理检查和组织活检。结果:630例被检患者中发现子宫颈病变人数为50例(7.94%),分别为子宫颈上皮内瘤变CINⅠ15例(2.38%)、CINⅡ1例(0.16%)、CINⅢ2例(0.32%),CINⅢ疑癌1例(0.16%),其余为子宫颈移行区的非正常细胞(ASC-US)31例(4.92%)。结论:液基细胞学薄层涂片技术及TBS系统在子宫颈癌早期筛查中的临床应用,有利于子宫颈癌的早期预防、早期诊断及早期治疗,能够使其在癌前病变时期得以诊断和治疗,极大程度的降低子宫颈癌发病率和病死率。
OBJECTIVE: To evaluate the clinical value of liquid-based cytology smear technique and TBS system in early screening of cervical cancer and diagnosis of cervical lesions. Methods: From March 16, 2007 to June 31, 2007, 630 patients with obstetrics and gynecology clinics in Chaoyang Central Hospital were diagnosed by TCT and TBS cytology. Colposcopy was performed on patients with abnormal TCT findings Check and organize biopsy. Results: The number of cervical lesions found in 630 cases was 50 cases (7.94%), which were CINⅠ (2.38%), CINⅡ (0.16%) and CINⅢ (0.32%) in cervical intraepithelial neoplasia CIN Ⅲ suspected cancer in 1 case (0.16%), the rest of the non-normal cervical cells (ASC-US) in 31 cases (4.92%). Conclusion: The liquid-based cytology smear technique and clinical application of TBS system in early screening of cervical cancer are beneficial to the early prevention, early diagnosis and early treatment of cervical cancer, and can be used in precancerous lesions Diagnosis and treatment, to a great extent reduce the incidence of cervical cancer and mortality.